Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders

Abstract Background Neuromyelitis Optica Spectrum Disorders (NMOSD) comprise a group of autoimmune-mediated, inflammatory, demyelinating central nervous system diseases caused by aquaporin-4 (AQP4) IgG autoantibodies. Efgartigimod is a human IgG Fc fragment that reduces antibody titers by targeting...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wenjing Yang, Pei Chen, Jiaxuan Guo, Huiyu Feng, Xin Huang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-12-01
Edice:	Orphanet Journal of Rare Diseases
Témata:	Neuromyelitis optica spectrum disorders Efgartigimod Intravenous methylprednisolone Treatment of acute phase
On-line přístup:	https://doi.org/10.1186/s13023-024-03501-6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!